These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35662289)

  • 1. Registry-based analysis of Icatibant and C1-inhibitor use in treatment of laryngeal attacks of hereditary angioedema.
    Hakl R; Kuklínek P; Sobotková M; Krčmová I; Králíčková P; Vachová M; Hanzlíková J; Nováčková M; Svoboda M; Kováčová I; Litzman J
    Clin Exp Allergy; 2022 Aug; 52(8):994-997. PubMed ID: 35662289
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
    Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
    J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report.
    Firinu D; Barca MP; Serusi L; Lorrai MM; Peralta MM; Manconi PE; Del Giacco SR
    Int J Immunopathol Pharmacol; 2012; 25(1):269-73. PubMed ID: 22507340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients.
    Federici C; Perego F; Borsoi L; Crosta V; Zanichelli A; Gidaro A; Tarricone R; Cicardi M
    BMJ Open; 2018 Jul; 8(7):e022291. PubMed ID: 30061443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Overview of Hereditary Angioedema for the Primary Care Physician.
    Sarkar A; Nwagwu C; Craig T
    Med Clin North Am; 2024 Jul; 108(4):747-755. PubMed ID: 38816115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic approaches in hereditary angioedema.
    Antoniu SA
    Clin Rev Allergy Immunol; 2011 Aug; 41(1):114-22. PubMed ID: 21279474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hereditary angioedema due to C1-esterase inhibitor deficiency : novel approaches].
    Stehlin F; Ribi C
    Rev Med Suisse; 2020 Apr; 16(689):675-678. PubMed ID: 32270933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allergy-immunology. New therapies for acute attacks in hereditary angioedema].
    Leimgruber A
    Rev Med Suisse; 2011 Jan; 7(278):103-5. PubMed ID: 21400938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
    Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
    Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema.
    Farkas H; Reshef A; Aberer W; Caballero T; McCarthy L; Hao J; Nothaft W; Schranz J; Bernstein JA; Li HH
    J Allergy Clin Immunol Pract; 2017; 5(6):1671-1678.e2. PubMed ID: 28601641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review results].
    Kawalec P; Holko P; Paszulewicz A; Obtułowicz K
    Pneumonol Alergol Pol; 2013; 81(2):95-104. PubMed ID: 23420425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Hereditary Angioedema.
    Caballero T
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):1-16. PubMed ID: 33602658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Treatments for Hereditary Angioedema.
    Johnson NM; Phillips MA
    Skin Therapy Lett; 2018 Jan; 23(1):6-8. PubMed ID: 29357215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hereditary angioedema. Treatment of acute attacks in Argentina].
    Malbrán A; Malbrán E; Menéndez A; Fernández Romero DS
    Medicina (B Aires); 2014; 74(3):198-200. PubMed ID: 24918666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of C1 inhibitor concentrate in hereditary angioedema with C1 inhibitor deficiency: Analysis in a French cohort.
    Belbézier A; Boccon-Gibod I; Thanh AD; Fain O; Bouillet L;
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):506-508. PubMed ID: 29964227
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic agents for hereditary angioedema.
    Giavina-Bianchi P; Motta A; Kalil J
    N Engl J Med; 2011 Jan; 364(1):85; author reply 86. PubMed ID: 21208116
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks.
    Hide M; Horiuchi T; Ohsawa I; Andresen I; Fukunaga A
    Allergol Int; 2021 Jan; 70(1):45-54. PubMed ID: 32919903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.
    Longhurst HJ; Zanichelli A; Caballero T; Bouillet L; Aberer W; Maurer M; Fain O; Fabien V; Andresen I;
    Clin Exp Immunol; 2017 Apr; 188(1):148-153. PubMed ID: 27936514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary angioedema--therapies old and new.
    Morgan BP
    N Engl J Med; 2010 Aug; 363(6):581-3. PubMed ID: 20818894
    [No Abstract]   [Full Text] [Related]  

  • 20. Icatibant for the treatment of hereditary angioedema.
    Cole SW; Lundquist LM
    Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.